Skip to main content

5 Result(s)

within B. M. Meiser Remove this filter

and

  1. No Access

    Article

    Cell Transplantation—A Potential Therapy for Cardiac Repair in the Future?

    Adult human myocardium lacks the possibility of regeneration because cardiac muscle cells do not reenter the cell cycle. Transplantation of myoblasts, cardiomyocytes, and stem-cell-derived cardiomyocytes has b...

    H. Gulbins, B. M. Meiser, B. Reichart in Cardiovascular Engineering: An Internation… (2001)

  2. No Access

    Article

    Herztransplantation — State of the Art Today

    Nach Ausschöpfung aller pharmakologischen und interventionellen Therapieansätze bleibt als letzte Behandlungsmöglichkeit der terminalen Herzinsuffizienz die Herztransplantation. Bei dem nach wie vor herrschend...

    B. M. Meiser, W. von Scheidt, M. Weis, D. Böhm, F. Kur, J. Koglin… in Herz (1997)

  3. No Access

    Article

    CP-123,369: A potent, orally active immunosuppressive agent

    K. Koch, D. C. Hanson, M. F. Newborg, K. Cooper, H. G. Fouda… in Inflammation Research (1995)

  4. No Access

    Chapter and Conference Paper

    Ein neuer chimärischer monoklonaler CD4 Antikörper zur Immunsuppression nach Herztransplantation

    For the first time, a new chimeric monoclonal CD4 antibody (chim CD4 mAb) was used to prevent rejection in the early postoperative period after heart transplantation (HTx). The chim mAb consists of a murine CD...

    B. M. Meiser, Ch. Reiter, M. Ebel… in Fortschritte in der Chirurgie im letzten J… (1992)

  5. No Access

    Chapter and Conference Paper

    Rapamycin: A New and Highly Active Immunosuppressive Macrolide with an Efficacy Superior to Cyclosporine

    In 1975, as part of a program at Ayerst Research Laboratories in Montreal to screen for non-polyene antifungal antibiotics, Dr Sehgal’s group (Sehgal 1975) discovered that a fermentation product of the fungus Str...

    B. M. Meiser, J. Wang, R. E. Morris in Progress in Immunology (1989)